EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacogenetic Approaches to Personalized SSRI Therapy

Aadi Balsaraf

Pittsburgh Undergraduate Review · 16.11.2026 · 5 (2)

DOI: 10.5195/pur.2026.192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pittsburgh Undergraduate Review, online erschienen am 16.11.2026. Verfasst von Aadi Balsaraf. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A complicated interaction of pharmacokinetic (PK), pharmacodynamic (PD), genetic, and epigenetic factors influences inter-individual variability in response to selective serotonin reuptake inhibitors (SSRIs). This review summarizes recent findings in antidepressant pharmacogenetics, emphasizing the functions of important pharmacodynamic loci (SLC6A4, HTR2A, BDNF, ABCB1) and metabolic genes (CYP2C19, CYP2D6) in regulating drug exposure, efficacy, and tolerability. Evidence from observational studies and previous reports suggests that pharmacogenomic-guided therapy may improve treatment outcomes, especially for individuals with abnormal metabolic profiles or treatment resistance. Major obstacles to clinical translation include small effect sizes, population-specific heterogeneity, retrospective studies, and uneven integration with therapeutic drug monitoring. Additional implementation barriers include workflow integration, patient access, cost, and clinical education. To optimize the clinical impact of precision psychiatry, future research should focus on prospective, multicenter trials with diverse populations, standardized clinical decision frameworks, and integration of polygenic, epigenetic, and environmental data. This review investigates whether integrating pharmacogenomic information into SSRI prescribing can enhance treatment outcomes and reduce adverse events.

Zitieren

APA

Balsaraf, A. (2026). Pharmacogenetic Approaches to Personalized SSRI Therapy. Pittsburgh Undergraduate Review, 5(2). https://doi.org/10.5195/pur.2026.192

Vancouver

Balsaraf A. Pharmacogenetic Approaches to Personalized SSRI Therapy. Pittsburgh Undergraduate Review. 2026;5(2). doi:10.5195/pur.2026.192

BibTeX
@article{Balsaraf2026,
  author = {Balsaraf, Aadi},
  title = {Pharmacogenetic Approaches to Personalized SSRI Therapy},
  journal = {Pittsburgh Undergraduate Review},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.5195/pur.2026.192}
}
Kostenlos starten →